SEC Form 4 · accession 0001209191-18-021763
ChronoScale Holdings Corp · CHRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Max Scheder-Bieschin
Officer — Chief Financial Officer
Period of report
Mar 22, 2018
Accepted (ET)
Mar 27, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001549084
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 22, 2018 | A | 57,325 | $0.00 | A | 89,696 | D | |
| Common StockF1 | Mar 23, 2018 | F | 17,836 | $1.5408 | D | 71,860 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.56, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.